price
IR
NASDAQ · IRWD
Ironwood Pharmaceuticals, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$4.68
Up+$0.29 (+6.61%)
Updated Nov 10, 2026, 2:59 AM
SID Score
6.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 598.66M
- P/E ratio
- 7.07
- Dividend yield
- 0.00%
- 52-week range
- $3.02 – $4.88
- Volume
- 5.33M
- Avg. volume
- 2.12M
Price performance · IRWD
IRWD price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 6, 2026
IRWD closed at $4.39 after 20 trading sessions, up 16.76% for the selected period.
- Last close
- $4.39
- Period change
- +16.76%
- Period low
- $3.46
- Period high
- $4.39
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | $4.26 | $4.44 | $4.10 | $4.39 | 3.96M |
| Nov 5, 2026 | $4.30 | $4.41 | $3.84 | $4.03 | 4.99M |
| Nov 4, 2026 | $3.61 | $3.80 | $3.58 | $3.77 | 2.57M |
| Nov 3, 2026 | $3.51 | $3.57 | $3.40 | $3.50 | 1.95M |
| Nov 2, 2026 | $3.50 | $3.585 | $3.4332 | $3.46 | 1.3M |
| Oct 30, 2026 | $3.59 | $3.64 | $3.45 | $3.50 | 1.47M |
| Oct 29, 2026 | $3.65 | $3.695 | $3.575 | $3.62 | 1.37M |
| Oct 28, 2026 | $3.46 | $3.63 | $3.46 | $3.61 | 1.41M |
| Oct 27, 2026 | $3.52 | $3.545 | $3.45 | $3.51 | 1.66M |
| Oct 26, 2026 | $3.49 | $3.535 | $3.45 | $3.50 | 1.13M |
| Oct 23, 2026 | $3.52 | $3.536 | $3.38 | $3.46 | 1.26M |
| Oct 22, 2026 | $3.50 | $3.605 | $3.49 | $3.57 | 1.04M |
| Oct 21, 2026 | $3.68 | $3.69 | $3.521 | $3.55 | 1.52M |
| Oct 20, 2026 | $3.57 | $3.71 | $3.525 | $3.63 | 1.64M |
| Oct 19, 2026 | $3.53 | $3.59 | $3.475 | $3.56 | 1.68M |
| Oct 16, 2026 | $3.73 | $3.73 | $3.48 | $3.50 | 2.53M |
| Oct 15, 2026 | $3.63 | $3.87 | $3.63 | $3.77 | 2.04M |
| Oct 14, 2026 | $3.55 | $3.63 | $3.51 | $3.60 | 1.22M |
| Oct 13, 2026 | $3.74 | $3.78 | $3.545 | $3.59 | 2.11M |
| Oct 12, 2026 | $3.82 | $3.85 | $3.74 | $3.76 | 1.04M |
Latest IRWD news
The latest Smart Investors Daily articles mentioning IRWD.
Stock researchCompany · Earnings
Company
Market Activity
Research & News
Loading stock research…

